Ancient herbal combo could speed healing in pancreatitis
NCT ID NCT07712081
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests whether adding a traditional Chinese herbal enema (Tongfu Qinghua Decoction) and an external herbal powder (Ruyi Jinhuang Powder) to standard medical care can help adults with acute pancreatitis recover faster. The trial enrolled 100 people aged 18 to 75 with their first episode of pancreatitis. Participants received either standard care alone or standard care plus the herbal treatments for 5 days. Researchers measured overall recovery, hospital stay length, pain relief, and lab markers like amylase and C-reactive protein.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Tongfu Qinghua Decoction enema and Ruyi Jinhuang Powder external application
- What this could lead to
- If effective, this combination therapy could offer a low-cost, low-risk way to speed recovery and reduce hospital stays for acute pancreatitis patients.
- What could go wrong
- This is a small, single-center study with no blinding, so results may not be generalizable. The herbal mixture is complex and not standardized, making replication difficult.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of acute pancreatitis according to established clinical diagnostic criteria. * Age 18 to 75 years. * First episode of acute pancreatitis with no treatment received before enrollment. * Voluntary participation and provision of written informed consent. Exclusion Criteria: * Presence of an indication for surgical intervention. * Pre-existing severe gastrointestinal disease. * Significant organ dysfunction or another severe underlying disease. * Pregnancy or breastfeeding. * A mental or psychiatric condition that prevented effective participation in the study. * Any contraindication to traditional Chinese medicine enema treatment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute pancreatitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ruian People's Hospital (The Third Affiliated Hospital of Wenzhou Medical University)
Rui’an, Zhejiang, 325200, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vast image library unlock better pancreatic diagnoses?
- Can a single infusion prevent organ failure in severe pancreatitis?
- Blood cell ratios may flag dangerous pancreatitis early
- A simple IV fluid choice could tame pancreatitis severity
- Can we predict acute pancreatitis outcomes?
- Blood test could spot deadly pancreatic infection earlier